Published in PLoS One on July 11, 2014
Structural Basis of the Recruitment of Ubiquitin-specific Protease USP15 by Spliceosome Recycling Factor SART3. J Biol Chem (2016) 0.78
Micelle-Based Adjuvants for Subunit Vaccine Delivery. Vaccines (Basel) (2015) 0.77
CTLA-4 control over Foxp3+ regulatory T cell function. Science (2008) 12.67
Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res (2007) 4.95
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood (2007) 2.65
Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol (2006) 2.49
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol (2009) 2.10
Agonistic CD40 antibodies and cancer therapy. Clin Cancer Res (2013) 1.95
Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood (2012) 1.61
The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol (2009) 1.57
Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev (2002) 1.56
Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med (1998) 1.50
Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective. Cancer Res (2012) 1.48
New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood (2003) 1.35
Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res (1999) 1.31
Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity. J Am Chem Soc (2008) 1.30
Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Int J Cancer (2013) 1.15
Biodegradable polyamino acid-based polycations as safe and effective gene carrier minimizing cumulative toxicity. Biomaterials (2010) 1.12
Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug Chem (1997) 1.12
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo. Cancer Immunol Immunother (2012) 1.10
Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem Soc Rev (2011) 1.10
A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival. Clin Cancer Res (2010) 1.05
Dendritic cell-based cancer gene therapy. Hum Gene Ther (2009) 1.02
Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration. J Pharm Sci (1985) 1.01
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles. Cancer Immunol Immunother (2006) 0.97
A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte. Gene Ther (2005) 0.91
Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett (2012) 0.89
Identification of CD8alpha+CD11c- lineage phenotype-negative cells in the spleen as committed precursor of CD8alpha+ dendritic cells. Blood (2002) 0.88
First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen. Cancer Sci (2012) 0.88
Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum Gene Ther (2010) 0.88
Insights into peptide-based vaccine design for cancer immunotherapy. Curr Med Chem (2005) 0.87
Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines. J Immunother (2010) 0.87
Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes. Int J Cancer (2000) 0.87
Strategies to use immune modulators in therapeutic vaccines against cancer. Semin Oncol (2012) 0.86
Role of GM-CSF signaling in cell-based tumor immunization. Blood (2009) 0.86
PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses. Mol Ther (2012) 0.84
A GM-CSF/CD40L producing cell augments anti-tumor T cell responses. J Surg Res (2005) 0.83
Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal dissemination. J Control Release (2012) 0.81
Design of clinical trials for therapeutic cancer vaccines development. Eur J Pharmacol (2009) 0.80
Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors. Biomaterials (2012) 0.80
Mouse homologue of the human SART3 gene encoding tumor-rejection antigen. Jpn J Cancer Res (2000) 0.79
Block/homo polyplex micelle-based GM-CSF gene therapy via intraperitoneal administration elicits antitumor immunity against peritoneal dissemination and exhibits safety potentials in mice and cynomolgus monkeys. J Control Release (2013) 0.76
Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching. J Hepatobiliary Pancreat Sci (2015) 1.52
Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Digestion (2015) 1.13
Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition. Lab Invest (2014) 0.88
CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells. Cancer Lett (2016) 0.82
Remote transmission of live endoscopy over the Internet: Report from the 87th Congress of the Japan Gastroenterological Endoscopy Society. Dig Endosc (2015) 0.81
Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Int J Cancer (2016) 0.81
Follicular pancreatitis, report of a case clinically mimicking pancreatic cancer and literature review. Pathol Res Pract (2013) 0.80
CD166/ALCAM expression is characteristic of tumorigenicity and invasive and migratory activities of pancreatic cancer cells. PLoS One (2014) 0.80
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors. Clin Immunol (2016) 0.79
TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells. Int J Oncol (2015) 0.79
CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression. Mol Carcinog (2015) 0.79
Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors. Hypertens Res (2013) 0.78
Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas. Dig Endosc (2015) 0.78
Small Nucleolar Noncoding RNA SNORA23, Upregulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of SYNE2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Gastroenterology (2017) 0.76
Small-sized, flat-type invasive branch duct intraductal papillary mucinous neoplasm: a case report. Case Rep Gastroenterol (2013) 0.76
Pancreatic Cancer: Clinical Significance of Biomarkers. Gastrointest Tumors (2013) 0.75
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer. Oncotarget (2017) 0.75
Clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study. Eur J Cancer (2015) 0.75
GNAS and KRAS mutational analyses of intraductal papillary neoplasms of the pancreas and bile duct developing in the same individual: A case report. Pancreatology (2015) 0.75
[Current strategy to cure pancreatic cancer]. Nihon Geka Gakkai Zasshi (2002) 0.75
The potential role of perivascular lymphatic vessels in preservation of kidney allograft function. Clin Exp Nephrol (2016) 0.75
Reduced-port laparoscopic restorative proctocolectomy without diverting ileostomy. Asian J Endosc Surg (2015) 0.75
Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer. Int J Oncol (2014) 0.75